• Call
  • Email
  • Branches
  • SMS
Broking
: 1800 300 29999 (Toll free) Dial 1 for Call N Trade (8:30am-11:30pm, Mon-Fri & 10am-2pm, Sat)
MyUniverse
:: 022-6180 2828
(10am-7pm, Mon-Sat)
Get to a branch closest to you
 ABML Branches
 ABML & ABMML Branches
 ABMML Retail
 ABMML Wealth Management
To reach us for any of our services, SMS the below short codes to 567679
  1. Broking/Distribution SMS: ABM to 567679
  2. Wealth Management SMS: ABMM to 567679
  3. Corporate & Treasury SMS: SOLUTIONS to 567679
  4. Real Estate Advisory SMS: PROPERTY to 567679
  5. Channel Partner SMS: CP to 567679
  6. Franchisee Partner: ABM to 567679
  7. Portfolio Management Services: ABMCS 567679
Share with us your valuable feedback
SENSEX 27257.6421.98 0.08%
NIFTY 8417.0019.00 0.23%
SENSEX 27257.6421.98 0.08% NIFTY 8417.0019.00 0.23%
Market Today
Company LTP() Prev. Close() Change() Change(%)
Tata Steel 467.60 454.20 13.40 2.95
Hind. Unilever 864.60 840.55 24.05 2.86
O N G C 197.85 194.90 2.95 1.51
M & M 1,216.10 1,205.65 10.45 0.87
TCS 2,295.00 2,277.65 17.35 0.76
St Bk of India 257.60 256.15 1.45 0.57
Index Charts
  • Sensex
  • NIfty
News
Jan 18 , 2017 15:38
The announcement was made during market hours today, 18 January 2017.

Meanwhile, the BSE Sensex was up 21.98 points, or 0.08%, to 27,257.64

On the BSE, 93,000 shares were traded in the counter, compared with average daily volumes of 64,465 shares in the past one quarter. The stock had hit a high of Rs 359.30 and a low of Rs 351.30.

The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had underperformed the market over the past 30 days till 17 January 2017, sliding 6.04% compared with the 3.26% rise in the Sensex. The scrip also underperformed the market in past one quarter, sliding 10.42% as against Sensex's 2.68% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1

Cadila Healthcare said that the company has received final approval from the US Food and Drug Administration (USFDA) for Methotrexate tablets USP. 2.5 mg, a chemotherapy drug used for leukemias, lymphnomas, breast cancer, lung cancer, head and neck cancers and other cancers. The drug will be produced at group's formulations manufacturing facility at the pharma special economic zone in Ahmedabad. The group now has more than 105 approvals and has so far filed nearly 275 Abbreviated New Drug Applications (ANDAs) since the commencement of the filing process in the financial year ended 31 March 2004.

Cadila Healthcare during trading hours yesterday, 17 January 2017 announced settlement with Kowa Company, Kowa Pharmaceuticals America and Nissan Chemical Industries on Livalo tablets. The stock had gained 0.19% to settle at Rs 349.80 yesterday, 17 January 2017.

On a consolidated basis, net profit of Cadila Healthcare declined 28.97% to Rs 337.60 crore on 3.08% rise in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

 Full Story
Corporate Actions
Company Name Date Purpose
Abhishek Finle. 19-Jan-17 Abhishek Finlease Ltd has informed BSE that..
Alembic 19-Jan-17 Alembic Ltd has informed BSE that a Meeting..
Ashirwad Cap. 19-Jan-17 Ashirwad Capital Ltd has informed BSE that ..
Axis Bank 19-Jan-17 AXIS Bank Ltd has informed BSE that the mee..
BFL Developers 19-Jan-17 BFL Developers Ltd has informed BSE that th..
Market Barometer
Name Close Price() Volume Weight In Index(%)
Tata Consultancy Ser.. 2,295.00 452,213.21 9.65
Reliance Industries .. 1,032.45 334,908.49 7.15
HDFC Bank Ltd 1,243.95 317,875.76 6.78
ITC Ltd 250.90 304,124.97 6.49
Oil & Natural Gas Co.. 197.85 253,905.56 5.42
Infosys Ltd 950.90 218,416.47 4.66
Products
ATTENTION INVESTORS :
Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Prevent Unauthorized Transactions in your Demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL / CDSL on the same day......................issued in the interest of investors. "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Securities Broking is through Aditya Birla Money Limited; NSE - SEBI Registration No.: Equity/ Debt - INB 23 1347031, Derivatives – INF 23 1347031, Currency – INE 23 1347031; BSE-SEBI Registration No.: Equity/ Debt - INB 01 1347037, Derivatives - INF 01 1347037, Currency- Exchange Registered; MSEI - SEBI Registration No.: Equity – INB 26 1347034 and Derivative – INF 26 1347034, Currency - INE 26 1347031; USE - SEBI Registration No.: Currency – INE 27 1347036. NSDL /CDSL : IN-DP-17-2015. Commodity Broking is through Aditya Birla Commodities Broking Limited; NCDEX Membership No.: 00158; MCX Membership No.28730; FMC Registration No.: NCDEX / TCM / CORP / 0180; MCX / TCM / CORP / 0023. National Spot Exchange Membership No : 12590. Mutual Fund Distribution is through Aditya Birla Money Mart Limited, ARN 0003. Life Insurance is through Aditya Birla Money Insurance Advisory Services Limited, licensed to act as a Corporate Agent of Birla Sun Life Insurance Company Limited. IRDA license no. BSL 308007. The services of myuniverse.co.in are offered by Aditya Birla Customer Services Limited. Currently as a Member, we are not engaged in proprietary trading.

Copyright © 2014. Aditya Birla Money Limited All Rights Reserved. Developed and Powered by C-MOTS Infotech (ISO 9001:2008 certified)